Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases

Cleo Keppens1, Elke Boone2, Paula Gameiro3

  • 1Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Kapucijnenvoer 35 block d, 1st floor, box 7001, 3000, Leuven, Belgium.

Insights

External quality assessment (EQA) participation significantly improves immunoglobulin (IG) and T-cell receptor (TR) gene rearrangement analysis in lymphoid malignancy diagnostics. Repeated EQA rounds reduce performance gaps between laboratories and sample types, emphasizing the need for ongoing education.

Area of Science:

  • Molecular diagnostics
  • Immunogenetics
  • Oncology

Background:

  • Clonality analysis of immunoglobulin (IG) and T-cell receptor (TR) gene rearrangements is crucial for diagnosing lymphoid malignancies.
  • External quality assessment (EQA) programs are essential for identifying and rectifying laboratory performance issues.

Purpose of the Study:

  • To evaluate the improvement in IG/TR analysis and interpretation by laboratories over five EQA rounds (2014-2018).
  • To assess the impact of repeated EQA participation on laboratory performance and identify areas for improvement.

Main Methods:

  • Participants analyzed five paper-based and five wet cases for IG and TR testing annually.
  • Performance was evaluated based on the accuracy of molecular conclusions and routine protocol analysis.
  • Statistical analysis compared performance between EuroClonality and non-EuroClonality labs, and across EQA rounds.

Main Results:

  • High accuracy rates were observed: 94.9% for IG wet, 97.9% for IG paper, 96.8% for TR wet, and 93.2% for TR paper.
  • Laboratory analysis scores significantly improved with increased EQA participation (p=0.001).
  • EuroClonality laboratories demonstrated significantly higher overall performance (99% IG, 97% TR) compared to non-EuroClonality labs (95% IG, 93% TR).

Conclusions:

  • Repeated EQA participation effectively reduces performance disparities among laboratories and across different sample types.
  • The study highlights the need for continuous education through meetings and EQA schemes, particularly for interpreting complex oligoclonal cases.

Related Concept Videos